 The purpose of this research study is:1 to determine if high doses of chemotherapy without total body irradiation can allow selected stem cells to take and grow,2 to determine if selected stem cells from the blood or marrow can take and not cause a complication called graft-versus-host disease GvHD and 3 to evaluate the side effects of the combination of chemotherapy drugs used for these transplants. In the last 10 years we have developed chemotherapy combinations to be used for this T-cell depleted transplant protocol. By using three chemotherapy drugs IV busulfan, melphalan and fludarabine, we hope to have a good chemotherapy combination to kill cancer cells, and to make the graft take, without the side effects of total body irradiation. The chemotherapy drugs to be tested in this protocol are busulfan, melphalan and fludarabine, all of which have been used successfully for stem cell transplantation, but not given together as in this specific regimen. This is what is being tested in this study. 